The Discounted Cash Flow (DCF) valuation of OncoCyte Corp (OCX) is (245.18) USD. With the latest stock price at 2.39 USD, the upside of OncoCyte Corp based on DCF is -10358.8%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 8.1% | 6.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,200.80) - (137.92) | (245.18) |
| Upside | -50342.8% - -5870.7% | -10358.8% |